FDA panel backs first multi-cancer blood test, Galleri, confirming safety and recommending continued routine screenings for adults 50 and older.

Agendia's landmark FLEX Study reaches a major enrollment milestone, accelerating real-world insights to advance more personalized breast cancer care Agendia, Inc., a leader in precision oncology for ...

Agendia’s landmark FLEX Study reaches a major enrollment milestone, accelerating real-world insights to advance more personalized breast cancer care ...

The panelists expressed reservations about the evidence supporting Grail’s Galleri test, which is designed to detect cancers ...

A panel of outside experts advising the US FDA said ​on Wednesday the benefits of Grail's blood-based cancer detection test outweigh ‌its risks, paving the way for a potential landmark approval in ...

A blood test designed to spot signs of multiple cancers in apparently healthy people faces its first major regulatory hurdle Wednesday as advisers to the U.S. government review how well it works.

Grail’s Galleri test looks for 50 cancers from a blood draw, but a major study failed to prove it could detect later-stage ...

The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts weighed ...

A new study found a blood test could identify some women at higher risk of recurrence of early triple negative breast cancer months before it became detectable through standard follow-up. But there’s ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new blood test may detect the return of breast cancer, a new study ...

University Medical Center New Orleans cut the ribbon Monday on the first phase of an expanded cancer center, doubling its exam rooms from nine to 18 and adding 10 more in a new annex after the ...